← Open Payments lookup

LUKE BROWN: Open Payments

NPI 1780295725 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$398 in 20 payments from 12 companies in 2025. Trend: 2023 $1,815 · 2024 $567 · 2025 $398

Food & beverage: $398
CompanyPaymentsAmount
ABBVIE INC.6$119
AstraZeneca Pharmaceuticals LP3$49
Phathom Pharmaceuticals, Inc.2$39
INTERNATIONAL REHABILITATIVE SCIENCES, INC1$38
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$24
Astellas Pharma US Inc1$23
Amgen Inc.1$20
Eisai Inc.1$20
Lilly USA, LLC1$19
Novo Nordisk Inc1$18

Products named: VRAYLAR, VOQUEZNA, RS-4i Plus with Intersperse, CREON, BREZTRI, XIFAXAN, Veozah, FARXIGA.

Industry payments across TX — which companies pay providers there.